Beyond antimicrobials: a host-directed precision pharmacotherapy framework for septic shock.

Area of Science:

• Critical care medicine
• Immunology
• Precision medicine

Background:

• Septic shock remains a leading cause of death in intensive care units, despite advances in antibiotics and supportive care.
• Current treatments are limited by the diverse and heterogeneous host immune responses to infection, leading to varied clinical outcomes.
• A paradigm shift towards modulating the host response, rather than solely focusing on pathogen control, is crucial for improving patient prognosis.

Purpose of the Study:

• To propose and scrutinize an integrated precision medicine framework for managing septic shock.
• To explore the scientific basis, clinical applications, and implementation strategies for this framework.
• To identify challenges and future directions for advancing individualized septic shock treatment.

Main Methods:

• Review and synthesis of current research on host immune responses in septic shock.
• Examination of multidimensional host endotyping techniques.
• Discussion of targeted therapeutic strategies and real-time monitoring with dynamic feedback loops.

Main Results:

• The proposed framework integrates host endotyping, targeted therapies, and dynamic monitoring for personalized septic shock management.
• This approach addresses the heterogeneity of immune responses, which is a key limitation of current treatment strategies.
• Potential clinical applications and pathways for implementation are discussed, alongside current obstacles.

Conclusions:

• An integrated precision medicine framework offers a promising strategy to overcome limitations in current septic shock management.
• Individualized modulation of host immune responses is essential for improving patient outcomes in septic shock.
• Further research and development are needed to fully realize the potential of precision medicine in critical care settings.